Internal Medicine, Pulmonary Disease Medicine
This clinician is not accepting new patients at this time. If you are a current patient, please contact the office.
Naftali Kaminski, MD, chief of Yale Medicine Pulmonary, Critical Care and Sleep Medicine, is a leader in improving the understanding and treatment of chronic lung diseases. He has a particular interest in idiopathic pulmonary fibrosis, a disease characterized by progressive scarring of the lungs, and in chronic obstructive pulmonary disease and asthma.
Dr. Kaminski leads the Kaminski Lab at Yale School of Medicine, where researchers apply cutting-edge technologies that measure changes in the sequence, expression or regulation of all the genes in the human genome in efforts to learn more about the roles of genome networks and biomarkers in chronic lung disease.
“Pulmonary fibrosis was an understudied and poorly understood disease, with high mortality and morbidity,” says Dr. Kaminiski, who is a professor of medicine (pulmonary) at Yale School of Medicine “I thought that by shifting the focus to human
relevant pathways and mechanisms we can have an impact, and we have.”
Does this provider accept my Insurance?
YES! This insurance is accepted.
Sorry This insurance may not be accepted.
Please check for your insurance on the list below.
Insurance coverage regularly changes, please contact the doctor’s office directly to verify that your specific insurance plan is accepted.
More About Accepted Insurance
789 Howard Avenue
2nd Floor
New Haven, CT 06519
Main (203) 495-2410
Fax (203) 737-6964
6 Devine Street
North Haven, CT 06473
Main (203) 495-2410
Fax (203) 239-8290
Are you Naftali Kaminski, MD?
Update your profile
